Skip to main content

This Week Could Bring FDA Approval of Fall COVID-19 Vaccines

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 21, 2024.

By Physician’s Briefing Staff HealthDay Reporter

TUESDAY, Aug. 20, 2024 -- Updated COVID-19 vaccines may receive approval from the U.S. Food and Drug Administration this week.

Two sources familiar with the issue told CNN that updated mRNA vaccines from Moderna and Pfizer that target the KP.2 variant could be greenlit as early as this week. The news agency said the sources declined to be named because information around the timing of approval has not yet been made public. It is not clear whether approval for the Novavax non-mRNA shot, targeted to the JN.1 strain, would be approved simultaneously.

If approval does come this week, that would be a few weeks ahead of the timing for last fall's shots, which were approved on Sept. 11.

The news comes as Americans are suffering through a summer surge of COVID-19 cases -- the highest seen since the summer of 2022, based on wastewater levels of virus tracked by the U.S. Centers for Disease Control and Prevention.

According to CDC data, the prevalent COVID-19 variant is now KP.3.1.1, thought to make up 37 percent of cases over the past two weeks. Still, experts note that although levels of severe disease have been rising, they remain much lower than those seen during the early years of the pandemic. KP.3.1.1 and KP.2, which are both covered in the updated shots, are offshoots of JN.1. All are members of the omicron family.

Both Moderna and Pfizer have said they have ample supplies of their updated COVID-19 vaccines on hand, ready for shipment to stores soon after FDA approval. The Novavax vaccine may take a bit longer to reach consumers, because its protein-based shot takes longer to manufacture than mRNA vaccines do.

In June, the CDC recommended that every American older than 6 months of age receive an updated COVID-19 shot along with the flu shot this year.

CNN Article

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2024

Further Support and Information on COVID-19

Read this next

Index of Symptoms Can Identify Long COVID in Children, Adolescents

THURSDAY, Aug. 22, 2024 -- Postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) can be identified using an index of symptoms, which...

2020 to 2021 Saw Decline in Life Expectancy for 39 States, Increase for 11

WEDNESDAY, Aug. 21, 2024 -- From 2020 to 2021, life expectancy at birth declined for 39 U.S. states and increased for 11 states, according to the Aug. 21 National Vital Statistics...

Study Quantifies COVID-19-Linked Deficit in Arthroplasties in the U.K.

THURSDAY, Aug. 15, 2024 -- The COVID-19-induced deficit in arthroplasty procedures is equivalent to 71.6 percent of a year of normal expected operating activity, according to a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.